Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032

Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032

The global organ-on-chip market size is expected to reach USD 1388.30 million by 2032, according to a new study by Polaris Market Research. The report “Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for organs on chips is growing mostly because of government efforts to limit the use of animal models in drug testing. Variables like improvements in fabrication technologies and the growing acceptance of organ-on-chip technology by biotechnology and pharmaceutical businesses also aid the development of this industry. However, the poor throughput of existing organ-on-chip technology combined with the technical complexity of the organ-on-chip models presents a partial barrier to industry growth.

Since the onset of COVID-19, the biopharmaceutical industry and scientific community have become more proactive, making Organ-on-chip technology highly adaptable for developing medications and vaccines during the pandemic. In essence, the novel coronavirus has become a lucrative opportunity for the organ-on-a-chip sector, with continual growth anticipated in the forecast period.

Multi-organ-on-chip (MOC) systems have been created to mimic the functions of multiple organs and facilitate inter-organ communication. They are valuable for studying drug responses and assessing drug toxicity across various organs simultaneously. MOCs play a crucial role in safety assessments within the cosmetic and food industries, offering efficient compound testing methods without the need for animal testing.

In cosmetics, miniature human skin, eyes, and other relevant organ models enable the safety evaluation of ingredients and final products. MOCs can be customized with specific cells to study how unique skin biology interacts with certain compounds. By including digestive organs, MOCs can also evaluate nutrients for developing personalized and nutritious food items. These chips present an innovative approach to replacing traditional animal models and toxicity testing.

Organ-On-Chip Market Report Highlights

The drug discovery segment dominated the market in 2023, driven by significant demand for in vitro tissue models that replicate human organ functions to aid in drug development.

The pharmaceutical & biotechnology companies segment led the market in 2023 and is expected to maintain its dominance due to significant investments in research & development along with the requirement for advanced drug testing methods.

North America holds a significant revenue share in the global organ-on-chip market, driven by key market players and government initiatives.

The global key market players include AlveoliX AG, AxoSim, BICO - the bio convergence company, CN Bio Innovations Ltd, Emulate, Inc., MIMETAS B.V., Nortis, Inc., SynVivo, Inc., The Charles Stark Draper Laboratory, Inc, and Valo Health

Polaris Market Research has segmented the organ-on-chip market report based on type, application, end-user, and region:

Organ-On-Chip, Organ Type Outlook (Revenue - USD Million, 2019 - 2032)

Heart

Lung

Liver

Intestine

Kidney

Others

Organ-On-Chip, Application Outlook (Revenue - USD Million, 2019 - 2032)

Drug Discovery

Toxicology Research

Stem Cell Research

Physiological Model Development

Tissue Regeneration & Regenerative Medicines

Organ-On-Chip, End-User Outlook (Revenue - USD Million, 2019 - 2032)

Pharmaceutical & Biotechnology Companies

Academic and Research Institutes

Organ-On-Chip, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa